Search Results - "Shepard DR"

Consensus recommendations in the management of jaw (gnathic) osteosarcoma.

Authors: Dietz MS Davis LE Prasad PK et al.

Source: Cancer [Cancer] 2026 Mar 01; Vol. 132 (5), pp. e70273.

Publication Type: Consensus Statement; Journal Article; Review

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C-Mutated Tumors.

Authors: Dumbrava EE Shapiro GI Parikh AR et al.

Source: The New England journal of medicine [N Engl J Med] 2026 Feb 26; Vol. 394 (9), pp. 872-883.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE

Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma.

Authors: Lauer UM Awada A Postel-Vinay S et al.

Source: ESMO open [ESMO Open] 2025 May; Vol. 10 (5), pp. 104499. Date of Electronic Publication: 2025 Apr 08.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study

Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE

Salvage stereotactic body radiation therapy re-irradiation for unresectable locally recurrent nasopharyngeal rhabdomyosarcoma in a young adult: A case report.

Authors: Buchberger DS Cook SK Anderson PM et al.

Source: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 Oct; Vol. 70 (10), pp. e30548. Date of Electronic Publication: 2023 Jul 17.

Publication Type: Case Reports; Letter; Research Support, Non-U.S. Gov't

Journal Info: Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE

A Single-Arm Phase 2 Trial of Trametinib in Patients with Locally Advanced or Metastatic Epithelioid Hemangioendothelioma.

Authors: Schuetze SM Ballman KV Heise R et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Oct 15; Vol. 30 (20), pp. 4584-4592.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.

Authors: Saif MW Becerra CR Fakih MG et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2021 Sep; Vol. 88 (3), pp. 485-497. Date of Electronic Publication: 2021 Jun 07.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors.

Authors: Michaelson MD Gupta S Agarwal N et al.

Source: The oncologist [Oncologist] 2019 Sep; Vol. 24 (9), pp. 1151-e817. Date of Electronic Publication: 2019 Jun 06.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

Accuracy of Time to Treatment Initiation Data in Musculoskeletal Soft Tissue Sarcoma.

Authors: Lawrenz JM Vega JF George J et al.

Source: Sarcoma [Sarcoma] 2023 May 23; Vol. 2023, pp. 9022770. Date of Electronic Publication: 2023 May 23 (Print Publication: 2023).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: Egypt NLM ID: 9709257 Publication Model: eCollection Cited Medium: Print ISSN: 1357-714X (Print) Linking ISSN: 1357714X NLM ISO Abbreviation: Sarcoma Subsets: PubMed not MEDLINE

Open-label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.

Authors: Saif MW Rosen L Rudek MA et al.

Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Jun; Vol. 85 (6), pp. 1239-1246. Date of Electronic Publication: 2019 Mar 28.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [¹⁴C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.

Authors: Gupta N Zhang S Pusalkar S et al.

Source: Investigational new drugs [Invest New Drugs] 2018 Jun; Vol. 36 (3), pp. 407-415. Date of Electronic Publication: 2017 Sep 21.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Adult soft tissue sarcoma and time to treatment initiation: An analysis of the National Cancer Database.

Authors: Curtis GL Lawrenz JM George J et al.

Source: Journal of surgical oncology [J Surg Oncol] 2018 Jun; Vol. 117 (8), pp. 1776-1785. Date of Electronic Publication: 2018 Jun 27.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE

Lack of pharmacokinetic drug-drug interaction between ramucirumab and irinotecan in patients with advanced solid tumors.

Authors: Wang D Braiteh F Lee JJ et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Oct; Vol. 78 (4), pp. 727-33. Date of Electronic Publication: 2016 Aug 09.

Publication Type: Journal Article

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Lack of pharmacokinetic drug-drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors.

Authors: Chow LQ Smith DC Tan AR et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Aug; Vol. 78 (2), pp. 433-41. Date of Electronic Publication: 2016 Jul 05.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Evaluation of the effect of necitumumab on the corrected QT interval in patients with advanced solid tumors.

Authors: Smith DC Powderly J Lee JJ et al.

Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2016 Aug; Vol. 78 (2), pp. 271-80. Date of Electronic Publication: 2016 Jun 16.

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE

Intratumoral Injection of Clostridium novyi-NT Spores in Patients with Treatment-refractory Advanced Solid Tumors.

Authors: Janku F Zhang HH Pezeshki A et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Jan 01; Vol. 27 (1), pp. 96-106. Date of Electronic Publication: 2020 Oct 12.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

A phase II study of tandutinib (MLN518), a selective inhibitor of type III tyrosine receptor kinases, in patients with metastatic renal cell carcinoma.

Authors: Shepard DR Cooney MM Elson P et al.

Source: Investigational new drugs [Invest New Drugs] 2012 Feb; Vol. 30 (1), pp. 364-7. Date of Electronic Publication: 2010 Aug 14.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309330 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-0646 (Electronic) Linking ISSN: 01676997 NLM ISO Abbreviation: Invest New Drugs Subsets: MEDLINE

Time to Treatment Initiation and Survival in Adult Localized High-Grade Bone Sarcoma.

Authors: Lawrenz JM Featherall J Curtis GL et al.

Source: Sarcoma [Sarcoma] 2020 May 04; Vol. 2020, pp. 2984043. Date of Electronic Publication: 2020 May 04 (Print Publication: 2020).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: Egypt NLM ID: 9709257 Publication Model: eCollection Cited Medium: Print ISSN: 1357-714X (Print) Linking ISSN: 1357714X NLM ISO Abbreviation: Sarcoma Subsets: PubMed not MEDLINE

Who Needs What? Perceptions of Patients and Caregivers in Oncology Phase 1 Trials.

Authors: Rezash V Reed J Gedeon B et al.

Source: Journal of patient experience [J Patient Exp] 2020 Feb; Vol. 7 (1), pp. 27-33. Date of Electronic Publication: 2019 Feb 19.

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: United States NLM ID: 101688338 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2374-3735 (Print) Linking ISSN: 23743735 NLM ISO Abbreviation: J Patient Exp Subsets: PubMed not MEDLINE

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer.

Authors: Fong L Hotson A Powderly JD et al.

Source: Cancer discovery [Cancer Discov] 2020 Jan; Vol. 10 (1), pp. 40-53. Date of Electronic Publication: 2019 Nov 15.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.

Authors: Peereboom DM Shepard DR Ahluwalia MS et al.

Source: Journal of neuro-oncology [J Neurooncol] 2010 May; Vol. 98 (1), pp. 93-9. Date of Electronic Publication: 2009 Dec 04.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE